Brand names: Recarbrio
Renal Dehydropeptidase Inhibitor · Penem Antibacterial · beta Lactamase Inhibitor · Dipeptidase Inhibitors · beta Lactamase Inhibitors
2 interactions on record
7 DRUG INTERACTIONS Ganciclovir: Avoid concomitant use. ( 7.2 ) 7.1 Ganciclovir Generalized seizures have been reported in patients who received ganciclovir concomitantly with imipenem/cilastatin, a component of RECARBRIO. Ganciclovir should not be used concomitantly with RECARBRIO unless the potential benefits outweigh the risks.
Source: FDA drug label - imipenem anhydrous, cilastatin, and relebactam anhydrous
( 7.2 ) 7.1 Ganciclovir Generalized seizures have been reported in patients who received ganciclovir concomitantly with imipenem/cilastatin, a component of RECARBRIO. 7.2 Valproic Acid Based on case reports in the literature concomitant use of carbapenems, including imipenem/cilastatin, components of RECARBRIO, with valproic acid or divalproex sodium may decrease valproic acid concentrations which may increase the risk of breakthrough seizures [see Warnings and Precautions (5.3) ] .
Source: FDA drug label - imipenem anhydrous, cilastatin, and relebactam anhydrous